【24h】

Pathogenomics: An updated European Research Agenda.

机译:病理基因组学:最新的欧洲研究议程。

获取原文
获取原文并翻译 | 示例
           

摘要

The emerging genomic technologies and bioinformatics provide novel opportunities for studying life-threatening human pathogens and to develop new applications for the improvement of human and animal health and the prevention, treatment, and diagnosis of infections. Based on the ecology and population biology of pathogens and related organisms and their connection to epidemiology, more accurate typing technologies and approaches will lead to better means of disease control. The analysis of the genome plasticity and gene pools of pathogenic bacteria including antigenic diversity and antigenic variation results in more effective vaccines and vaccine implementation programs. The study of newly identified and uncultivated microorganisms enables the identification of new threats. The scrutiny of the metabolism of the pathogen in the host allows the identification of new targets for anti-infectives and therapeutic approaches. The development of modulators of host responses and mediators of host damage will be facilitated by the research on interactions of microbes and hosts, including mechanisms of host damage, acute and chronic relationships as well as commensalisms. The study of multiple pathogenic and non-pathogenic microbes interacting in the host will improve the management of multiple infections and will allow probiotic and prebiotic interventions. Needless to iterate, the application of the results of improved prevention and treatment of infections into clinical tests will have a positive impact on the management of human and animal disease. The Pathogenomics Research Agenda draws on discussions with experts of the Network of Excellence "EuroPathoGenomics" at the management board meeting of the project held during 18-21 April 2007, in the Villa Vigoni, Menaggio, Italy. Based on a proposed European Research Agenda in the field of pathogenomics by the ERA-NET PathoGenoMics the meeting's participants updated the established list of topics as the research agenda for the future.
机译:新兴的基因组技术和生物信息学为研究威胁生命的人类病原体以及开发新的应用程序提供了新的机会,以改善人类和动物的健康以及预防,治疗和诊断感染。基于病原体和相关生物的生态学和种群生物学及其与流行病学的联系,更准确的分型技术和方法将导致更好的疾病控制手段。对病原菌的基因组可塑性和基因库的分析(包括抗原多样性和抗原变异)可产生更有效的疫苗和疫苗实施方案。对新发现和未培养的微生物的研究可以识别新的威胁。对宿主中病原体代谢的详细检查可以确定抗感染和治疗方法的新靶标。微生物与宿主相互作用的研究,包括宿主损伤的机制,急性和慢性关系以及共鸣,将促进宿主反应调节剂和宿主损伤介体的发展。对宿主中多种致病性和非致病性微生物相互作用的研究将改善多种感染的管理,并允许益生菌和益生元干预。无需反复进行,将改进的感染预防和治疗结果应用于临床试验将对人类和动物疾病的管理产生积极影响。在2007年4月18日至21日在意大利梅纳焦的Villa Vigoni举行的该项目的管理委员会会议上,《病理基因组研究议程》借鉴了卓越网络“ EuroPathoGenomics”专家的讨论。基于ERA-NET PathoGenoMics提出的有关病原学领域的欧洲研究议程,会议的与会者更新了已建立的主题列表,作为未来的研究议程。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号